Streetbeat News

Products Services

MSFT

A new ChatGPT jailbreak allows users to use the AI for humor, including roasting people. The jailbreak was discovered by Andrew Burkard and requires a ChatGPT Plus subscription. Microsoft-backed OpenAI, which has several guardrails in place to prevent misuse of ChatGPT, has seen previous jailbreaks, including one involving Bing Chat's Sydney persona.

Portfolio Pulse from Rounak Jain

October 13, 2023 | 4:12 pm

AMD

INTC

NVDA

Advanced Micro Devices, Inc (AMD) and Nvidia Corp (NVDA) stocks are trading lower amid reports of the U.S. intensifying its semiconductor technology sanctions against China. The U.S. is reportedly closing a loophole that allowed Chinese companies to access American AI chips through overseas units. Analysts indicate a growing potential for AMD and Intel Corp (INTC) despite Nvidia's dominance in the AI GPU market. Nvidia's plans to shift to a one-year release cadence could pose a problem for AMD and Intel, which are still on a two-year release cadence for GPUs and AI accelerators.

Portfolio Pulse from Anusuya Lahiri

October 13, 2023 | 4:07 pm

BGNE

BeiGene's BRUKINSA (zanubrutinib) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for use in relapsed or refractory follicular lymphoma. The CHMP recommends approval for BRUKINSA plus obinutuzumab as a treatment for adult patients who have received at least two prior lines of therapy. If approved, BRUKINSA will be the first and only BTK inhibitor approved for follicular lymphoma.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 3:51 pm

BTI

NFLX

The FDA has banned the sale of menthol Vuse electronic cigarettes and a fruit-flavored nicotine product from Vuse. The products are manufactured by British American Tobacco's Reynolds American business. The FDA is also considering action against the company's tobacco-flavored vapes. Altria Group, which owns a stake in Juul, has also faced scrutiny from the FDA. The rise and fall of Juul is documented in a Netflix documentary.

Portfolio Pulse from Aaron Bry

October 13, 2023 | 3:33 pm

GNLN

SMORF

TLLTF

Senior analyst Pablo Zuanic from Zuanic & Associates provides an in-depth report on the key players in the cannabis hardware and vaping sector. Smoore International Holdings Limited (OTC:SMORF) leads the industry as the world's largest supplier of vaping product components. Major distributors of CCELL products in the U.S. include Jupiter Research (OTC:TLLTF) and Greenlane Holdings (NASDAQ:GNLN). The report recommends that CCELL and its distribution network adapt to evolving market trends to maintain and regain market share.

Portfolio Pulse from Nicolás Jose Rodriguez

October 13, 2023 | 2:59 pm

DIS

TikTok has secured a significant deal with Disney, which includes a content hub and publisher partnership. The deal is expected to boost TikTok's content offerings and increase its user engagement.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 2:58 pm

INCY

Incyte (NASDAQ:INCY) has announced new data from the Phase 3 TRuE-AD3 study evaluating the safety and efficacy of ruxolitinib cream (Opzelura®) in children with atopic dermatitis (AD). The study met its primary endpoint with significantly more patients treated with ruxolitinib cream achieving Investigator's Global Assessment Treatment Success (IGA-TS) than patients treated with vehicle control. The cream was well tolerated with no serious infections, major adverse cardiovascular events, malignancies or thromboses reported during the 8-week vehicle-controlled period.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 2:35 pm

AKRO

EDSA

PLTR

PLUG

TUP

Benzinga's Stock Whisper Index highlights five stocks that warrant attention for the week of Oct. 13, 2023. These include Edesa Biotech Inc (EDSA), which announced a reverse stock split and secured a financial commitment from Canada's government for a Phase 3 clinical study; Palantir Technologies (PLTR), which secured a $250 million contract from the U.S. Department of Defense; Akero Therapeutics (AKRO), which saw a sharp drop in shares after disappointing Phase 2b study results; Tupperware Brands Corp (TUP), which saw increased volatility and trading after amendments to an existing credit agreement; and Plug Power Inc (PLUG), which saw increased investor attention after updating its long-term revenue guidance.

Portfolio Pulse from Chris Katje

October 13, 2023 | 2:26 pm

VERA

Vera Therapeutics (NASDAQ:VERA) announced that three abstracts on its product candidate atacicept in immunoglobulin A nephropathy (IgAN) have been selected for poster presentations at the American Society of Nephrology (ASN) Kidney Week 2023. The presentations will include data from the ORIGIN 3 Pivotal Phase 3 study and additional analysis of week 36 data from Phase 2b ORIGIN study. The data supports atacicept's potential as a long-term disease-modifying IgAN therapy.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 2:25 pm

HRMY

Harmony Biosciences Holdings Inc (NASDAQ:HRMY) announced topline results from the INTUNE Phase 3 study of pitolisant in patients with idiopathic hypersomnia (IH). Approximately 83% of patients responded positively to the treatment, however, no statistically significant difference was observed between pitolisant and placebo groups on the primary endpoint. The safety profile of pitolisant was consistent with previous findings. HRMY shares are down 36.20% at $19.30.

Portfolio Pulse from Vandana Singh

October 13, 2023 | 2:23 pm